Author: Oleg Barski
Oleg is a biochemist who manages grants in the area of enzymology and metabolism. He also manages individual postdoctoral fellowships and career development awards and serves as scientific/research contact for the Collaborative Program Grant for Multidisciplinary Teams (RM1) for the Division of Pharmacology, Physiology, and Biological Chemistry.
Posts by Oleg Barski
We’re offering another round of administrative supplements to provide summer research experiences to undergraduate students. The research experiences can be conducted remotely or in person, depending on the institutional regulations of the applicant organization. The supplements are open to all NIGMS-funded investigators with active R01, R35, and R37 awards, including those in their final year of funding. We’ll accept requests under PA-20-272, Administrative Supplements to Existing NIH Grants and Cooperative Agreements.
Continue reading “NIGMS Administrative Supplements to Support Undergraduate Summer Research”
We’re offering another round of administrative supplements to provide summer research experiences for undergraduate students. These supplements are open to all NIGMS-funded investigators with active R01, R35, and R37 awards, including those in their final year of funding. We’ll accept requests under PA-20-272, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional). The research experiences can be conducted remotely or in person, depending on the institutional policies of each applicant.
Continue reading “NIGMS Administrative Supplements to Support Undergraduate Summer Research”
We’re pleased to announce our participation in the Accelerating Leading-edge Science in ALS (ALS2) program (NOT-RM-20-019). ALS2 is a $25 million NIH Common Fund initiative to spur innovative research into the basic biology of amyotrophic lateral sclerosis (ALS) through the NIH Director’s Transformative Research Award. NIGMS encourages our community of basic scientists working on relevant processes to consider applying for this opportunity.
ALS is a devastating disease with no known cure. The development of effective therapeutics can benefit tremendously from basic ALS research that 1.) tests highly novel concepts, 2.) brings together researchers from different scientific perspectives, and 3.) applies powerful emerging technologies from a variety of disciplines.
Continue reading “ALS2 Funding Opportunity: Fundamental Research in Underlying Causes of Amyotrophic Lateral Sclerosis”
We’re offering administrative supplements to provide summer research experiences for undergraduate students. These supplements are open to all NIGMS-funded investigators with active R01, R35, and R37 awards, including those in their final year of funding or in a no-cost extension. We’ll accept requests under PA-18-591, Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional).
We wish to support students at any stage of their
undergraduate career. Students may be U.S. or non-U.S. citizens. We encourage principal
investigators to select students who otherwise would not have access to
research experiences to participate in this program. Only one request per principal
investigator will be considered.
Continue reading “NIGMS Administrative Supplements to Support Undergraduate Summer Research”
